AMN vs BMRN · rev $2.98B vs P/E 40, rev $2.85B
AMN Healthcare Services Inc (AMN) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.
AMN Healthcare Services Inc (AMN) is a medical care facilities company listed on US.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Latest reported AMN revenue for 2024-12-31 was $2.98B. Net income was -$147.0M. Revenue was down 21.3% from 2023-12-31 to 2024-12-31. AMN currently screens at market cap $1.23B.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
AMN currently screens at market cap $1.23B. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the AMN and BMRN stock pages for the full models.
Not investment advice.